Damora Therapeutics, Inc. (DMRA)
Nasdaq: DMRA · Pharmaceutical Preparations · Waltham, MA · filing with the SEC since 2020
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
| Report filed | Mar 19, 2026 | Mar 19, 2025 | Mar 8, 2024 | Mar 9, 2023 | Feb 17, 2022 | Mar 29, 2021 | · |
| For lenders | |||||||
| Net interest income | 1,167 | 844 | 1,689 | 722 | 156 | · | · |
| Research and development | 26,877 | 6,398 | 23,770 | 48,206 | 38,488 | 24,627 | 19,738 |
| General and administrative | 9,685 | 10,499 | 12,687 | 13,001 | 13,739 | 9,010 | 2,445 |
| Total operating expenses | 210,872 | 22,260 | 39,905 | 61,207 | 52,227 | 33,637 | 38,971 |
| Operating income | -210,872 | -22,260 | -39,905 | -61,207 | -52,227 | -33,637r | 38,971 |
| Total non-operating income (expense) | 1,083 | 862 | 1,556 | -417 | 475 | -1,200 | 2,464 |
| Income before income taxes | -209,789 | -21,398 | -38,349 | -61,624 | -51,752 | -34,837 | -36,507 |
| Income tax expense | 50 | 41 | 0 | 0 | 0 | 0 | 0 |
| Net income including non-controlling interests | -209,839 | -21,439 | -38,349 | -61,624 | -51,752 | -34,837 | -36,507 |
| Net income | -209,839 | -21,439 | -38,349 | -61,624 | -51,752 | -34,837 | -36,507 |
| Preferred dividends | · | · | · | · | · | · | 5,560 |
| Net income to common shareholders | · | · | · | · | · | -34,837 | -42,067 |
| Earnings per share, basic | 3.98 | -18.53 | -36.08r | -60.75b | -51.25b | · | · |
| Earnings per share, diluted | 3.98 | -18.53 | -36.08r | -60.75b | -51.25b | · | · |
| Earnings per share, basic and diluted | · | · | · | · | -51.25b | -190.50b | -4,045.50b |
| Weighted average shares, basic | 1,363,005 | 1,157,149 | 1,062,873r | 1,016,365b | 1,010,473b | · | · |
| Weighted average shares, diluted | 1,363,005 | 1,157,149 | 1,062,873r | 1,016,365b | 1,010,473b | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | 1,010,473b | 182,908b | 10,399b |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-25 reverse split of Aug 2024.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Net interest income interest earned less interest paid
us-gaap:InterestIncomeExpenseNetResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossPreferred dividends paid to preferred holders before common shareholders
us-gaap:PreferredStockDividendsIncomeStatementImpactNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted